Bispecific antibodies and their use in applied research
Bispecific antibodies (BsAb) can, by virtue of combining two binding specificities, improve the selectivity and efficacy of antibody-based treatment of human disease. Antibodies with two distinct binding specificities have great potential for a wide range of clinical applications as targeting agents...
Main Authors: | Harshit Verma, Durairajan Ramachandran, Ashabaree Samal |
---|---|
Format: | Article |
Language: | English |
Published: |
Veterinary World
2012-01-01
|
Series: | Veterinary World |
Subjects: | |
Online Access: | http://www.scopemed.org/fulltextpdf.php?mno=17729 |
Similar Items
-
Cancer Immunotherapy by Retargeting of Immune Effector Cells via Recombinant Bispecific Antibody Constructs
by: Slava Stamova, et al.
Published: (2012-07-01) -
Bispecific antibodies: design, therapy, perspectives
by: Sedykh SE, et al.
Published: (2018-01-01) -
Immunotherapy with Antibodies in Multiple Myeloma: Monoclonals, Bispecifics, and Immunoconjugates
by: Christie P. M. Verkleij, et al.
Published: (2021-03-01) -
A Novel Anti-HER2 Bispecific Antibody With Potent Tumor Inhibitory Effects In Vitro and In Vivo
by: Mehdi Mohammadi, et al.
Published: (2021-02-01) -
Bispecific Antibodies: A Smart Arsenal for Cancer Immunotherapies
by: Gihoon You, et al.
Published: (2021-07-01)